HRTX News and Press, Heron Therapeutics Inc. From 03/04/22

The following slide deck was published by Heron Therapeutics, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Heron Therapeutics, Inc. 2021 Q4 - Results - Earnings Call Presentation

So far, 2022 has been an ugly year for a lot of stocks. But if you look out over the next five years, you can find some amazing opportunities. Our roundtable of three Motley Fool contributors has found three biotech stocks that might be 11-baggers in five years. Patrick Bafuma is bullis...

Heron Therapeutics had a productive 2021 with several corporate and commercial achievements that will set the company up for future growth. Subsequently, Heron obtained approval for a substantially expanded indication only five months after launch. Furthermore, the company filed a...

Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference PR Newswire SAN DIEGO , March 2, 2022 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) a commercial-stage biotechnology company focused on improving the lives of patients by developin...

Shares of the small-cap biotech Heron Therapeutics (NASDAQ: HRTX) are down by a noteworthy 19.2% as of 2:48 p.m. ET Tuesday afternoon. The drugmaker's shares are cratering today in response to its disappointing 2021 fourth-quarter results. What's the specific culprit behind ...

Gainers: Avenue Therapeutics (NASDAQ:ATXI) +165%. CTI BioPharma (NASDAQ:CTIC) +60%. UserTesting (NYSE:USER) +31%. Oak Street Health (NYSE:OSH) +25%. iQIYI (NASDAQ:IQ) +24%. Veritiv (NYSE:VRTV) +18%. TaskUs (NASDAQ:TASK) +17%. Danimer Scientific (NYSE:DNMR) +17%. LivePerson (NASDAQ:LPSN) +16%....

Heron Therapeutics (HRTX -21.3%) stock fell following in Q4 results. Q4 net product sales rose +0.24% Y/Y to $20.66M, which failed to beat analysts' estimates.  Net product sales for ZYNRELEF were $0.8M in Q4. The pain drug became commercially available in the U.S. on July 1. The ap...

Gainers: CTI BioPharma (NASDAQ:CTIC) +40%. Oak Street Health (NYSE:OSH) +23%. AVITA Medical (NASDAQ:RCEL) +15%. Axsome Therapeutics (NASDAQ:AXSM) +14%. Protagonist Therapeutics (NASDAQ:PTGX) +12%. Losers: GoodRx Holdings (NASDAQ:GDRX) -40%. Semler Scientific...

Heron Therapeutics, Inc. (HRTX) Q4 2021 Results Conference Call February 28, 2022 04:30 PM ET Company Participants David Szekeres - EVP and COO Barry Quart - Chairman and CEO John Poyhonen - President and Chief Commercial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...